<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007547.ref018">
 <label>18</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Garcia-Arriaza</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Cepeda</surname>
   <given-names>V</given-names>
  </name>, 
  <name>
   <surname>Hallengard</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Sorzano</surname>
   <given-names>CO</given-names>
  </name>, 
  <name>
   <surname>Kummerer</surname>
   <given-names>BM</given-names>
  </name>, 
  <name>
   <surname>Liljestrom</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Esteban</surname>
   <given-names>M</given-names>
  </name> (
  <year>2014</year>) 
  <article-title>A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection</article-title>. 
  <source>J Virol</source>
  <volume>88</volume>: 
  <fpage>3527</fpage>â€“
  <lpage>3547</lpage>. JVI.03418-13 [pii]; 
  <pub-id pub-id-type="doi">10.1128/JVI.03418-13</pub-id>
  <?supplied-pmid 24403588?>
  <pub-id pub-id-type="pmid">24403588</pub-id>
 </mixed-citation>
</ref>
